Ligand validation:2IPL

BGC: beta-D-glucopyranose

BGC is a Ligand Of Interest in 2IPL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2IPL_BGC_A_501	88%	69%	0.109	0.985	0.45	0.7	-	-	0	0	100%	1
8FXT_BGC_A_404	91%	63%	0.096	0.984	0.43	0.96	-	-	0	0	100%	0.5
2FVY_BGC_A_310	85%	38%	0.101	0.966	1.44	1.09	2	1	0	0	100%	1
1HHU_BGC_C_8	100%	66%	0.037	0.997	0.6	0.68	-	-	0	0	100%	0.9167
2V3G_BGC_A_1281	100%	68%	0.051	0.994	0.52	0.69	-	-	0	0	100%	1
3ACT_BGC_B_3901	99%	47%	0.05	0.988	0.92	1.12	-	1	0	0	100%	1
3AFJ_BGC_A_2901	99%	59%	0.054	0.989	0.59	0.96	-	1	0	0	100%	1
7D9C_BGC_A_611	98%	41%	0.056	0.981	0.91	1.43	-	3	1	0	100%	0.318

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.